CLINICAL_TRIALS
trial_result
· 2013-12-05
Clinical Trial Update: Pazopanib in Treating Patients With Malignant Pleural Mesothelioma [Phase 2]
Summary
A Phase 2 clinical trial evaluating Pazopanib for malignant pleural mesothelioma has completed, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Malignant Mesothelioma, Localized Malignant Mesothelioma | Phase 2 | Status: COMPLETED | Results posted: 2013-12-05